Insights

Market Leadership Talecris is one of the largest producers and marketers of plasma-derived protein therapies globally, indicating significant market presence and potential for expanding sales within the biopharmaceutical and healthcare sectors.

Product Portfolio The company's extensive development and distribution of therapies for life-threatening conditions present opportunities to tailor solutions for hospitals, clinics, and specialty pharmacies seeking reliable plasma-based treatments.

Recent Legal Challenges Legal issues such as discrimination lawsuits and biometric privacy violations present an opening to offer compliance solutions, legal consultancy, or quality assurance services to support corporate risk mitigation.

Acquisition Growth Being acquired by Grifols and resulting in a substantial increase in product and sales portfolio suggests a focus on expansion and innovation, making the company receptive to partnerships in research, technology, and distribution channels.

Financial Scale With revenues ranging from $250 million to $500 million and a large employee base, Talecris offers substantial opportunities for enterprise solutions, supply chain optimization, and equipment or service procurement tailored to large-scale operations.

Similar companies to Talecris Biotherapeutics, Inc.

Talecris Biotherapeutics, Inc. Tech Stack

Media & News

Talecris Biotherapeutics, Inc.'s Email Address Formats

Talecris Biotherapeutics, Inc. uses at least 1 format(s):

Talecris Biotherapeutics, Inc. Email Formats	Example	Percentage
First.Last@talecris.com	John.Doe@talecris.com	80%
LastF@talecris.com	DoeJ@talecris.com	11%
Last.First@talecris.com	Doe.John@talecris.com	6%
FLast@talecris.com	JDoe@talecris.com	3%

Frequently Asked Questions

Where is Talecris Biotherapeutics, Inc.'s headquarters located?

Talecris Biotherapeutics, Inc.'s main headquarters is located at 79 t. West Alexander Drive 4101 Research Commons Alexander, North Carolina United States. The company has employees across 2 continents, including North AmericaAsia.

What is Talecris Biotherapeutics, Inc.'s phone number?

You can contact Talecris Biotherapeutics, Inc.'s main corporate office by phone at

+1-337-491-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Talecris Biotherapeutics, Inc.'s official website and social media links?

Talecris Biotherapeutics, Inc.'s official website is talecris.com and has social profiles on LinkedIn.

How much revenue does Talecris Biotherapeutics, Inc. generate?

As of February 2026, Talecris Biotherapeutics, Inc.'s annual revenue is estimated to be $5B.

What is Talecris Biotherapeutics, Inc.'s SIC code NAICS code?

Talecris Biotherapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Talecris Biotherapeutics, Inc. have currently?

As of February 2026, Talecris Biotherapeutics, Inc. has approximately 400 employees across 2 continents, including North AmericaAsia. Key team members include Evp R&d: S. P.Sr. Director Product Quality Management: J. P.Sr. Director Human Resources: S. J.. Explore Talecris Biotherapeutics, Inc.'s employee directory with LeadIQ.

What industry does Talecris Biotherapeutics, Inc. belong to?

Talecris Biotherapeutics, Inc. operates in the Biotechnology Research industry.

What is Talecris Biotherapeutics, Inc.'s email format?

Talecris Biotherapeutics, Inc.'s email format typically follows the pattern of First.Last@talecris.com. Find more Talecris Biotherapeutics, Inc. email formats with LeadIQ.

When was Talecris Biotherapeutics, Inc. founded?

Talecris Biotherapeutics, Inc. was founded in 2005.

Talecris Biotherapeutics, Inc.

Biotechnology ResearchNorth Carolina, United States201-500 Employees

We are a biopharmaceutical company that is one of the largest producers and marketers of plasma-derived protein therapies in the world. We develop, produce, market, and distribute therapies that extend and enhance the lives of people suffering from chronic and acute, often life-threatening, conditions, such as chronic inflammatory demyelinating polyneuropathy (CIDP), primary immune deficiencies (PI), alpha-1 antitrypsin deficiency, bleeding disorders, infectious diseases and severe trauma. Our products are derived from human plasma, the liquid component of blood, which is sourced from our plasma collection centers or purchased from third parties, located in the United States.

Company Overview

Headquarters: 79 t. West Alexander Drive 4101 Research Commons Alexander, North Carolina United States
Phone number: +1-337-491-****
Website: talecris.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2005
Employees: 201-500